US FDA Tiptoes Further Into Off-Label Use Discussions With CURE ID App

 
• By Derrick Gingery

App allows clinicians to discuss off-label treatments, but information is intended to be hypothesis-generating, not for regulatory use.

Render illustration of computer keyboard; with the print OFF-LABEL on a red button; and a small bottle of pillls.
Clinicians and non-clinicians may join the CURE ID app community and post case reports. • Source: Shutterstock

More from US FDA

More from Agency Leadership